Medical information Clinical review pending

Genetic Testing

CD36 Gene Platelet Glycoprotein IV Deficiency Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the CD36 gene associated with platelet glycoprotein IV deficiency, a condition affecting blood clotting. Essential for individuals with a family history of bleeding disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample, Extracted DNA, or One drop of blood on FTA Card.
Results: Confirm with the laboratory before booking.
Preparation: Provide a detailed clinical history. A genetic counseling session to draw a pedigree chart of family members affected by CD36 gene deficiencies is recommended before the test.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the CD36 Gene Platelet Glycoprotein IV Deficiency Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Family history of bleeding disorders
✓Unexplained bleeding or bruising
✓Assessment of bleeding risk before surgery
✓Diagnosis in individuals with thrombocytopenia
✓Genetic counseling for families with bleeding disorders

In plain language

What this test helps you understand

This test helps identify genetic mutations in the CD36 gene that cause platelet glycoprotein IV deficiency, aiding in the diagnosis and management of bleeding disorders related to platelet function.

The CD36 Gene Platelet Glycoprotein IV Deficiency NGS Genetic DNA Test is a diagnostic tool used to identify deficiencies in platelet glycoprotein, specifically focusing on the CD36 gene. This test employs Next Generation Sequencing (NGS) technology, providing a comprehensive analysis of the CD36 gene, which plays a significant role in platelet function and blood clotting. Understanding your genetic makeup is crucial, especially when it comes to conditions that affect hematological health. This test measures the presence of mutations in the CD36 gene that can lead to glycoprotein IV deficiencies. By assessing these genetic variations, healthcare providers can better understand potential risk factors associated with bleeding disorders. Results from the test will indicate whether any mutations are present. A genetic counseling session is recommended to help interpret the results and discuss potential implications for you and your family. Understanding these results can empower you to take proactive steps towards managing your health.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationProvide a detailed clinical history. A genetic counseling session to draw a pedigree chart of family members affected by CD36 gene deficiencies is recommended before the test.

SampleBlood sample, Extracted DNA, or One drop of blood on FTA Card.

MethodologyNext Generation Sequencing (NGS) analysis of the CD36 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the CD36 gene. Other genetic or non-genetic factors can also cause bleeding disorders. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This is a genetic condition where there is a deficiency in platelet glycoprotein IV, a protein important for blood clotting. It can lead to increased bleeding tendencies.

Individuals with a family history of bleeding disorders, unexplained bruising or bleeding, or those undergoing surgery may benefit from this test.

The test involves analyzing a sample of your blood or DNA to look for specific mutations in the CD36 gene using Next Generation Sequencing (NGS).

Results indicate the presence or absence of mutations in the CD36 gene. A genetic counseling session is recommended to understand the implications of the results.

Genetic counseling is recommended to help interpret results and discuss family implications, but please confirm availability and cost with the laboratory.

We have branches across Kenya, including Nairobi, Mombasa, and Kisumu. Contact us at +254711564616 to book your test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp